NCT06794970 Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation
| NCT ID | NCT06794970 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Kidney Transplant |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2028-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-05-01 with a primary completion date of 2028-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is tissue-based, retrospective and prospective, single-centre, non-sponsored. Primary objective: To examine patient and organ survival and eGFR variation in kidney transplant patients diagnosed histologically with cAMR.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Kidney transplant recipients * eGFR\>15 ml/min/1.73 sq m at the time of diagnosis of cAMR * cAMR diagnosis defined on the basis of the 2018 Banff Classification (17), made after 1/1/2018. * Obtaining Informed Consent to Participation. Exclusion Criteria: * Combined transplant patients (heart-kidney, liver-kidney or kidney-pancreas) * Histological evidence of concomitant disease (e.g. recurrence of original nephropathy or diagnosis of 'de novo' nephropathy, acute cellular rejection, polyomavirus BK nephropathy, other)
Contact & Investigator
Gaetano La Manna, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06794970 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06794970 currently recruiting?
Yes, NCT06794970 is actively recruiting participants. Contact the research team at gaetano.lamanna@unibo.it for enrollment information.
Where is the NCT06794970 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06794970 clinical trial?
NCT06794970 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Gaetano La Manna, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.